What happened to @CELG?
CELG is defunct since November 24, 2019. Acquired by Bristol-Myers Squibb (BMY) Gilead an acquisition target? Deep pockets required
Who is the parent company of Celgene?
Celgene Corporation is a subsidiary of Bristol-Myers Squibb Company. Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
What does Celgene do for a living?
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. The company offers ABRAXANE, a paclitaxel powder for injectable suspension nanoparticle; IDHIFA that are enasidenib tablets; INREBIC, which are fedratinib capsules; ISTODAX, a lyophi...
See more
Barchart Technical Opinion
Business Summary
The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.
Celgene
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID,...
About CELG
Some stock charts might currently not be supported. To try again, please refresh this page.
